CHICAGO — An electronic frailty index may help to predict risk for poor outcomes, including mortality, in patients undergoing chemotherapy.“Chemotherapy treatment in older people often poses a difficult dilemma for clinicians,” Agnieszka Michael, PhD, MRCP, associate professor in oncology, consultant medical oncologist and medical director of Surrey Clinical Trials Unit at
New study aims to improve the treatment of patients receiving end-of-life care news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
E-Mail
The support app provides tailored advice to patients undergoing treatment for cancer,, and the app will be trialled in colorectal, breast and lung cancer patients across four NHS sites - helping them to better self-manage their medications, side effects, symptoms and lifestyles.
The app seamlessly integrates with smartphone technology, and it is hoped that its use can improve quality of life and reduce the use of emergency healthcare in patients undergoing treatment.
It is anticipated that 300 patients will be recruited, and randomised to receive either standard of care or standard of care and additional support through the app.
The trial will be sponsored by University of Surrey and run by Surrey Clinical Trials Unit, led by Professor Simon Skene and Dr Agnieszka Michael.